The Australian Government is undertaking an independent review of the regulatory arrangements for medicines and medical devices. RANZCO’s primary concerns in response to the Expert Panel’s discussion paper relate to patient safety; timely patient access to medicines; stable supply to reduce the advent of drug shortages; appropriate red tape for use of unapproved products; and incentives for sponsors to register medicines for niche ophthalmic indications.
RANZCO’s submission is available here.
In this submission RANZCO points out a number of areas for improvement in the Medical Board of Australia (MBA) draft revised standards covering the following limited registration categories: Postgraduate Training or Supervised Practice; Area of Need; Teaching or Research; and Public Interest. The College also welcomes the development of guidance to international medical graduates who apply to undertake short term training in a medical specialty in Australia.
RANZCO’s submission is available here.
In this submission RANZCO recommends significant reforms to the operation of the National Registration and Accreditation Scheme for health professionals. The College considers that patient safety is paramount and supports the resolution of cross professional issues by an independent body. RANZCO reaffirms its support of the Australian Medical Council as the accreditation body responsible for medical courses and vocational training.
RANZCO’s submission is available here.
